Changes to the website
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4457

Previous 25           Next 25
Website Changes
05/25/2017 Four Neuro-Oncology Experts to Lead New Glioblastoma Research Center at NewYork-Presbyterian
05/21/2017 New research finds an existing antibody can help kill cancer cells
05/20/2017 Market Research Opportunity for GBM Patients - ONLINE SURVEY
05/20/2017 Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
05/19/2017 Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
05/14/2017 Long-Term Follow-Up Data from 126 Patients with Recurrent High Grade Glioma from Three Phase 1 Trials of Toca 511 and Toca FC: Update and Justification for a Phase 2/3 Trial
05/14/2017 Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma.
05/14/2017 Tumor treating fields in pediatric high-grade glioma.
05/11/2017 First spherical nucleic acid drug injected into humans targets brain cancer
05/11/2017 Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors
05/08/2017 DelMar Presents New Mechanism of Action Data for its Lead Agent VAL-083 in Temozolomide-Resistant Glioblastoma Multiforme (GBM) at the World Federation of Neuro-Oncology Societies (WFNOS)
05/05/2017 Duke researchers develop treatment that triples survival time of brain cancer patients
05/04/2017 Research Reveals Non-coding RNA SPRIGHTLY Plays Important Role in Tumour Growth, Spread
05/04/2017 Brain cancer: Study sheds light on unexpected link between glioma and blood sugar
05/04/2017 Novocure (NVCR) to Open Two Pilot Trials to Evaluate the Use of TTFields for Pediatric
05/02/2017 Using CRISPR to Find Treatments For Aggressive Pediatric Brain Cancers
05/01/2017 Breakthrough brain tumour visualisation drug Gliolan to be listed on NZ hospital medicines list from 1 June
05/01/2017 Musella Foundation Copay Assistance Program reopens!
05/01/2017 Brain Tumor BioTech Conference June 2, 2017 in NY
04/26/2017 TARGETED THERAPY BEING TESTED IN SOCAL GIVES BRAIN CANCER PATIENTS HOPE
04/26/2017 Surgical success in previously “inoperable” brain cancers
04/26/2017 New Tupperware Fundraiser!
04/22/2017 Brains Matter Awareness Fundraiser and Celebration Luncheon / Now Accepting Nomination for our 2017 National Hope Award
04/21/2017 Pediatric Brain Tumor Mutations are Detectable in Cerebrospinal Fluid
04/20/2017 VBL Therapeutics Announces Positive DSMC Review in Phase 3 GLOBE Trial Investigating VB-111 in rGBM



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites